Seeing what you want to see in randomised controlled trials: Versions and perversions of UKPDS data

British Medical Journal

Volumn 320, Issue 7251, 2000, Pages 1720-1723

  McCormack, James ^a   Greenhalgh, Trisha ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROPAMIDE; GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DIABETES MELLITUS; DIET THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; MARKETING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNITED KINGDOM;

EID: 0034709738     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.320.7251.1720     Document Type: Review

References (13)

1. 1 University Group Diabetes Program. A.. study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1970:19(suppl 2):717-830.
2. 2 UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. 3 UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 1998;352:854-65.
4. 4 Ewart R. The UKPDS - what was the question? Lancet 1999;353:1882.
5. 5 Bailey CJ, Grant PJ. The UK prospective diabetes study [letter]. Lancet 1998;352:1932.
6. 6 Gerstein HC. Intensive blood glucose control reduced type 2 diabetes mellitus-related end points. ACP J Club www.acponline.org/journals/ acpjc/janfeb99/type2dm.htm (accessed 28 March 2000).
7. 7 Nathan DM. Some answers, more controversy, from UKPDS. United Kingdom prospective diabetes study. Lancet 1998;352:832-3.
8. 8 Sackett DL, Cook RJ. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452-4.
9. 9 Windeler J, Lange S. Events per person year - a dubious concept BMJ 1995;310:454-6.
10. 10 Greenhalgg T. How to read a paper: papers that report drug mals. BMJ 1997;315:480-3.
11. 11 Kerner R. Correspondence - UK prospective diabetes study. Lancet 1998;352:1934-5.
12. 12 Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al. Effects of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project (CAPPP) randomised trial. Lancet 1999;353:611-6.
13. 13 Janis IL. Groupthink: psychological studies of policy decisions and fiascos. Boston: Houghton Mifflin, 1982.